News

MedPage Today22h
FDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other Vaccines
The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...
STAT4h
8 possible indicators of how RFK Jr.’s HHS will handle vaccine policy
Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional ...
Clinical Pain Advisor22h
Novavax COVID Vaccine Moves Closer to Full FDA Approval
Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.
Pharma’s whirlwind 100 days
The FDA and other HHS agencies of interest to the pharma sphere have seen President Donald Trump’s first 100 days as he ...
BioSpace2h
Tariffs Continue to Dominate Q1 Earnings, AACR Excites Cancer Space, CEO Pay Gaps, More
As Q1 2025 earnings season continues, tariffs remain top of mind for pharma CEOs and investors. Meanwhile, the American Association for Cancer Research’s annual event kicks off this year’s oncology ...
FDA chief looking at whether to approve COVID shots for next winter
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...
MedPage Today on MSN23hOpinion
A Conversation With FDA Commissioner Marty Makary
Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...